Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial.
about
Buprenorphine for neuropathic pain in adultsBuprenorphine for treating cancer painOpioids for neuropathic painOpioids for neuropathic painTramadol for neuropathic painBuprenorphine: a unique drug with complex pharmacologyPain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients.Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic painPharmacological strategies for the management of cancer pain in developing countries.Pharmacokinetics of buprenorphine following intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta).Transdermal buprenorphine - a critical appraisal of its role in pain management.Pharmacokinetics of sustained-release and transdermal buprenorphine in Göttingen minipigs (Sus scrofa domestica).Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine.Transdermal opioids for cancer pain.Transdermal buprenorphine in the management of persistent pain - safety aspects.Buprenorphine disrupts sleep and decreases adenosine concentrations in sleep-regulating brain regions of Sprague Dawley rat.Transdermal patches: history, development and pharmacology.Transdermal buprenorphine in the treatment of chronic pain.Comparison between Transdermal Buprenorphine and Transdermal Fentanyl for Postoperative Pain Relief after Major Abdominal SurgeriesThe use of high dosages of transdermal buprenorphine for pain management in palliative cancer patients: a case study.Management of chronic pain in the elderly: focus on transdermal buprenorphine.Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review.Buprenorphine-naloxone therapy in pain management.Transdermal opioids as front line treatment of moderate to severe cancer pain: a systemic review.Systematic review of the role of alternative application routes for opioid treatment for moderate to severe cancer pain: an EPCRC opioid guidelines project.Safety and efficacy of transdermal buprenorphine for the relief of cancer pain.A meta-analysis of efficacy and tolerability of buprenorphine for the relief of cancer pain.Systematic review of adverse events of buprenorphine patch versus fentanyl patch in patients with chronic moderate-to-severe pain.Buprenorphine for cancer pain: is it ready for prime time?Pharmacological options for the management of refractory cancer pain-what is the evidence?The effectiveness of buprenorphine for treating cancer pain: an abridged Cochrane review.Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders.Transdermal Buprenorphine Patches for Postoperative Pain Control in Abdominal SurgeryTransdermal buprenorphine in clinical practice: a multicenter, postmarketing study in the Czech Republic, with a focus on neuropathic pain components.Transdermal buprenorphine for the treatment of cancer pain: results from a multicenter, observational, post-marketing study in Spain (RELIEF study).Transdermal buprenorphine in chronic pain: indications and clinical experience.Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients.Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine.Pharmacokinetics of 2 formulations of buprenorphine in macaques (Macaca mulatta and Macaca fascicularis).Use of immediate-release opioids as supplemental analgesia during management of moderate-to-severe chronic pain with buprenorphine transdermal system.
P2860
Q24186924-36365421-00FB-4F52-BBC0-92E3187622A1Q24187076-5F9B5E82-E4A0-42CE-B66C-48A5380AAD7FQ24200179-0D8CA28B-9E7B-402B-87F0-2CE7EAFEF1C3Q24245218-EF1117F2-53A3-45AD-A2FB-593097979953Q24245564-815E9C15-C303-4E7F-944D-75264D01A7A2Q24642980-B8E53140-2D03-4AC3-8AAF-7DB9D9272690Q25255339-1E88A995-DD2A-4520-A008-0FA1E25804FDQ26775658-12FF76F6-9D9C-4E28-906D-CE4F7177EF4CQ34134058-96E722F9-725C-4C3F-9A93-421B822C0495Q34175251-28FDA5F4-0B4E-460D-AD93-78CC776B288FQ34418193-5F802A31-9FC1-4D35-A74B-E1C71585935CQ34620060-F6FF4B82-10D5-425E-881F-30523F4E2C71Q34787766-1C05F117-1375-436B-85D5-4B8C926D9504Q34893726-63C7A7B0-F1BC-47B1-A3CA-B83DCA90DDFEQ35166793-B6135958-33E5-49E1-BFC7-B98AB89150FCQ35400818-8375C656-06FA-48F4-8D4E-E7CC8DF33402Q35484265-6678AFF8-A560-44F4-871E-083E2AC3F317Q36153362-495F1B29-DE18-4409-B517-994DD0A1AE61Q36476375-3451DD80-BDC6-4811-AD99-4EABE8C0ACC1Q36797096-4A749613-1111-42AB-8DB3-347EB1E295EDQ37316802-51B49F1A-1A91-4B83-9306-239093DD20F6Q37354641-6C0AB9BD-9901-4CE9-96A2-4AA76AF016EFQ37722356-B20C72C2-867E-43FC-961D-6A5A7D7A731AQ37894994-9D2E8AFE-41EC-4C04-8127-7086FCDD365FQ37895005-E2A41EEF-8162-4819-9A46-C4CCC37D4198Q38127157-22ABAE8E-53CF-4A7D-B9D6-0C5DAEC776A5Q38193819-B577D331-7BD3-4778-A5BA-E76E0E06C259Q38198100-87AD3C77-9257-41CD-96AC-CC77F34C8084Q38243938-2D171ACA-5408-48E0-A663-48B28B2CA27AQ38370071-C4365F2C-82E6-4F37-B92F-2813CE8344ADQ38669787-0637AF42-F9CB-44F5-847D-EC5007376520Q38857113-54F06216-17B5-4255-92B6-69658F906BA7Q39168922-563A8C03-64ED-45E1-A97E-41FBEF50038AQ39251330-8B8A085E-62ED-4561-AEF8-50D4D1B894BDQ39257066-E8AA549C-4123-4AC3-81CA-711D3497F06DQ39312604-6B3DDF9F-CE11-4326-8CF3-D531292B3269Q39334344-5C908A28-EE8D-4732-B406-FB86D38B4913Q39356288-A8042E08-1133-4A75-9F37-6BC5F531BACAQ41842602-AC12AEAE-077C-4754-B9BD-174568C30747Q42237962-7A5298E9-91A5-4E02-B152-1520ADADA223
P2860
Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Analgesic efficacy and tolerab ...... ind, placebo-controlled trial.
@en
Analgesic efficacy and tolerab ...... ind, placebo-controlled trial.
@nl
type
label
Analgesic efficacy and tolerab ...... ind, placebo-controlled trial.
@en
Analgesic efficacy and tolerab ...... ind, placebo-controlled trial.
@nl
prefLabel
Analgesic efficacy and tolerab ...... ind, placebo-controlled trial.
@en
Analgesic efficacy and tolerab ...... ind, placebo-controlled trial.
@nl
P2093
P921
P1476
Analgesic efficacy and tolerab ...... ind, placebo-controlled trial.
@en
P2093
Norbert Griessinger
Reinhard Sittl
Rudolf Likar
P304
P356
10.1016/S0149-2918(03)90019-1
P577
2003-01-01T00:00:00Z